cancerVidac Pharma Holding plc reports preclinical proof of principleLondon-based Vidac Pharma Holding plc reported that its Warburg effect blocker VDA-1275 increased efficacy of chemotherapeutics 1000-fold in human organoid cancer models for liver cancer. more ➔
FinancingRoche leads Freenome Inc US$257m financingMulti-omics liquid biospy specialist Freenome Inc. has baged US$254m in a financing round led by Roche AG to fund early cancer detection in 6,200 patients using its AI-guided cancer detection platfo … more ➔
BioplasticsBioplastics production capacity to quadruple by 2028New figures published by the industry association European Bioplastics suggest a sharp increase in the production of sustainable plastics in the next two years and calls for policy support. more ➔
financingAZmed closes €15m Series A financingParis-based AI-based medical imanging specialist AZmed SA has secured a €15min Series A financing led by Maison Worms, Techstars, and Tempact Ventures. more ➔
gene therapyBayer’s Ask Bio unit starts Phase II heart failure gene therapyBayer SE subsidiary Asklepios BioPharmaceutical Inc. (AskBio) has started Phase II testing of AB-1002 (NAN-101) in patients with congestive heart failure. more ➔
LabGerman companies to revolutionise lab plastics marketGerman Green Elephant Biotech has launched the world’s first plant-based 96-well microtitre plate on the market. more ➔
financingAMPLY Discovery Ltd bags £1.4m funding to tackle complex diseasesBelfast-based techbio company AMPLY Discovery Ltd announced today will make use of a £1.4m in grant funding to advance its AI-based drug discovery platform. more ➔
financingCambridge university spin-out HutanBio Ltd bags £2.25m seed financingBritish-Malasian marine algae biofuel start-up HutanBio has secured an £2.25m seed investment to produce carbon negative biodiesel in brackish water. more ➔
agri-biotechEU parliament backs deregulation of New Genome TechniquesAfter two "Yes"-votes in the European Parliament’s AGRI and ENVI committees, MEPs confirmed the European Commissions draft Regulation on New Genomic Technologies in plant breeding. … more ➔
partnershipJazz Pharmaceuticals licences KRAS blocker from Redx PharmaJazz Pharmaceuticals plc has entered an agreement with Redx Pharma to acquire commercialisation rights to Redx KRAS blockers, which include G12D selective and pan-KRAS molecules. more ➔
